e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

PTC Therapeutics, Inc. - Common Stock (NQ:PTCT)

78.47 +2.01 (+2.63%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about PTC Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

PTC Therapeutics Flashes A Bearish Sign After European Officials Reject DMD Drug ↗

January 26, 2024

European regulators will likely force PTC Therapeutics to pull its drug, Translarna, from the market.

Via Investor's Business Daily

PTC Therapeutics To Withdraw Its Conditionally Approved Rare Muscle Disorder Disorder Drug In Europe ↗

January 26, 2024

CHMP issues negative opinion on PTC Therapeutics' Translarna for Duchenne Muscular Dystrophy. CEO expresses disappointment.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 26, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 25, 2024

Via Benzinga

Analyst Expectations for PTC Therapeutics's Future ↗

November 20, 2023

Via Benzinga

Earnings Preview: PTC Therapeutics ↗

October 25, 2023

Via Benzinga

Expert Ratings for PTC Therapeutics ↗

September 19, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 27, 2023

Via Benzinga

Why Is Gene Therapy Player PTC Therapeutics Stock Plunging Today? ↗

October 27, 2023

In its Q3 earnings release, PTC Therapeutics Inc (NASDAQ: PTCT) reported a

Via Benzinga

ALGN Stock Alert: Align Technology Announces $250M Stock Buyback Program ↗

October 27, 2023

Align Technology stock is rising on Friday after the company announced plans to repurchase $250 million worth of ALGN shares.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 27, 2023

Via Benzinga

RBLX Stock Alert: Analysts Are Pounding the Table on Roblox ↗

October 27, 2023

Roblox stock is rising higher on Friday after analysts upgraded shares of RBLX and increased price targets for the gaming company.

Via InvestorPlace

Why Is PTC Therapeutics (PTCT) Stock Down 23% Today? ↗

October 27, 2023

PTC Therapeutics stock is falling on Friday as PTCT investors react to the company's lackluster earnings report for Q3 2023.

Via InvestorPlace

Amazon To Rally Around 55%? Here Are 10 Top Analyst Forecasts For Friday ↗

October 27, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

October 27, 2023

It's time to start off the final trading day this week with a breakdown of the biggest pre-market stock movers on Friday!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 26, 2023

Via Benzinga

Why PTC Therapeutics Soared 15% Higher Today ↗

October 19, 2023

The company scored a $1 billion upfront payment for expanding a commercial partnership.

Via The Motley Fool

Nasdaq Falls 100 Points; AT&T Posts Upbeat Earnings ↗

October 19, 2023

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling around 100 points on Thursday. The Dow traded down 0.43% to 33,520.17 while the NASDAQ fell 0.75% to 13,214.04. The...

Via Benzinga

Topics Stocks

Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

October 19, 2023

Gainers

Via Benzinga

AT&T, Union Pacific, Las Vegas Sands And Other Big Stocks Moving Higher On Thursday ↗

October 19, 2023

U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 30 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 19, 2023

Via Benzinga

NASDAQ:PTCT Shareholder Notice: Investigation over Possible Securities Laws Violations by PTC Therapeutics, Inc. ↗

October 10, 2023

San Diego, CA -- (SBWIRE) -- 10/10/2023 -- PTC Therapeutics, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.

Via SBWire

10 Health Care Stocks Whale Activity In Today's Session ↗

October 02, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023 ↗

October 06, 2023

Via Benzinga

Dell Technologies To Rally More Than 15%? Here Are 10 Other Analyst Forecasts For Tuesday ↗

September 19, 2023

Raymond James increased the price target for Vital Energy, Inc. (NYSE: VTLE) from $54 to $67. Raymond James analyst John Freeman maintained an Outperform rating. Vital Energy shares rose 0.5% to $54.37...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

October 02, 2023

On Monday, 369 companies set new 52-week lows.

Via Benzinga

Micron Technology To Rally Around 22%? Here Are 10 Other Analyst Forecasts For Monday ↗

September 18, 2023

Piper Sandler cut the price target for IBEX Limited (NASDAQ: IBEX) from $24 to $17. Piper Sandler analyst Arvind Ramnani maintained an Overweight rating. IBEX shares rose 0.3% to close at $13.59 on...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023 ↗

September 18, 2023

Via Benzinga

US Stock Futures Edge Higher Amid Cautious Optimism; Analyst Says How Fed Packages Sept. Pause Key For Market Direction ↗

September 18, 2023

US stock futures point to a higher opening on Monday after averages closed nearly flat in the week ended Sept. 15.

Via Benzinga

Topics Economy

European Authority Gives Thumbs Down To PTC Therapeutics' Duchenne Therapy; Analyst Says It Can Overturn The Challenge ↗

September 15, 2023

Friday morning, the Committee for Medicinal Products for Human Use of the European Medicines Agency gave a negative opinion on the conversion of the conditional marketing authorization to full...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy